GlycoMimetics Inc. (GLYC)
0.25
-0.01 (-3.36%)
At close: Mar 04, 2025, 10:49 AM
GlycoMimetics Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Revenue | n/a | 10K | 74.92K | 1.16M | 10.16M | n/a | n/a | n/a | 18K | 20.07M | 15.03M | 3.99M | 15.26M | 3.81M |
| Cost of Revenue | n/a | n/a | 1.03M | 1.01M | n/a | 899.3K | 275.12K | 263.54K | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit | n/a | 10K | -957.23K | 146.36K | 10.16M | -899.3K | -275.12K | -263.54K | 18K | 20.07M | 15.03M | 3.99M | 15.26M | 3.81M |
| Operating Income | -40.04B | -39.28M | -47.4M | -63.45M | -51.51M | -61.39M | -51.51M | -33.93M | -31.91M | -12.78M | -11.14M | -10.59M | 3.66M | -6.08M |
| Interest Income | 935.27M | 2.38M | 715K | 20K | 482K | 3.5M | 3.23M | n/a | n/a | 15K | n/a | n/a | 20.99K | 8.39K |
| Pretax Income | n/a | -36.9M | -46.69M | -63.43M | -51.03M | -57.89M | -48.27M | -33.28M | -31.81M | -12.77M | -11.12M | -10.61M | 3.66M | -6.11M |
| Net Income | n/a | -36.9M | -93.33M | -63.14M | -50.27M | -54.12M | -48.27M | -33.28M | -31.81M | -12.77M | -11.12M | -10.61M | 3.66M | -6.11M |
| Selling & General & Admin | 18.25B | 19.21M | 19.09M | 17.11M | 16.74M | 14.36M | 11.41M | 9.83M | 8.65M | 7.8M | 6.6M | 2.88M | 2.16M | 2.1M |
| Research & Development | 14.26B | 20.07M | 28.39M | 47.49M | 44.93M | 47.03M | 40.09M | 24.1M | 23.28M | 25.05M | 19.57M | 11.7M | 9.44M | 7.8M |
| Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | 3.23M | 651.21K | 104K | 15K | 18K | -17.76K | -26.61K | -36.78K |
| Operating Expenses | 32.51B | 39.29M | 47.48M | 64.61M | 61.67M | 61.39M | 51.51M | 33.93M | 31.93M | 32.85M | 26.17M | 14.58M | 11.6M | 9.9M |
| Interest Expense | n/a | n/a | 46.64M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 18K | 894K | n/a | n/a |
| Selling & Marketing Expenses | n/a | 637.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -17.76K | n/a | n/a |
| Cost & Expenses | 40.04B | 39.29M | 47.48M | 64.61M | 61.67M | 61.39M | 51.51M | 33.93M | 31.93M | 32.85M | 26.17M | 14.58M | 11.6M | 9.9M |
| Income Tax | n/a | -637 | 46.64M | -284.6K | -752.75K | -3.78M | 3.23M | n/a | -190.54K | -191.48K | -158.71K | -894 | -20.99K | -8.39K |
| Shares Outstanding (Basic) | 64.48M | 63.34M | 52.53M | 51.45M | 45.72M | 43.25M | 41.04M | 29.4M | 21.26M | 19.01M | 18.45M | 1.2M | 1.2M | 1.2M |
| Shares Outstanding (Diluted) | 64.48M | 63.34M | 52.53M | 51.45M | 45.72M | 43.25M | 41.04M | 29.4M | 21.26M | 19.01M | 18.45M | 1.2M | 1.2M | 1.2M |
| EPS (Basic) | -0.59 | -0.58 | -1.78 | -1.23 | -1.1 | -1.25 | -1.18 | -1.13 | -1.5 | -0.67 | -0.6 | -8.87 | 3.06 | -5.11 |
| EPS (Diluted) | -0.59 | -0.58 | -1.78 | -1.23 | -1.1 | -1.25 | -1.18 | -1.13 | -1.5 | -0.67 | -0.6 | -8.87 | 3.06 | -5.11 |
| EBITDA | -40.04B | -39.12M | -47.2M | -63.18M | -51.24M | -56.99M | -51.23M | -33.67M | -31.72M | -12.59M | -10.98M | -10.47M | 3.76M | -6M |
| Depreciation & Amortization | n/a | 153.3K | 1.03M | 1.01M | 951.6K | 899.3K | 275.12K | 263.54K | 190.54K | 191.48K | 158.71K | 133.05K | 99.92K | 83.86K |